{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:13:34Z","timestamp":1793924014114,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Parker B Francis Fellowship Program"},{"DOI":"10.13039\/501100000938","name":"Department of Veterans' Affairs, Australian Government","doi-asserted-by":"publisher","award":["CDA 22-140"],"award-info":[{"award-number":["CDA 22-140"]}],"id":[{"id":"10.13039\/501100000938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RCS 23-081"],"award-info":[{"award-number":["RCS 23-081"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pulmonary hypertension (PH) is a progressive disease leading to right heart failure and early mortality. Early recognition of the disease and timely initiation of PH-specific therapies for qualifying PH subgroups are crucial for improving patient outcomes. Yet delays in diagnosis and treatment of PH persist. We aimed to explore patient and provider perspectives on access to and timeliness of PH care across the patient\u2019s entire health journey from symptom onset through follow-up care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a multi-site qualitative study at three expert PH centers in the United States. We interviewed 41 key informants including 21 patients and 20 providers (physicians, physician assistants, PH pharmacists, and PH nurses). Guided by a conceptual model of the care continuum adapted to PH, we analyzed transcripts using a directed content analysis with both deductive (based on our conceptual model) and inductive coding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found barriers to timely access to PH care along the entire care continuum from symptom onset through receiving longitudinal PH care. Geographic barriers to care, limited non-expert PH knowledge, dismissal of patient\u2019s symptoms by providers, limited PH expert availability, and inadequate insurance coverage of PH medications emerged as the most prominent barriers to PH care access. Participants offered clear and specific solutions to address these care gaps, including establishing telementoring models to improve non-expert PH knowledge, building relationships between PH experts and community providers to bolster referral networks, leveraging technology to mitigate geographic barriers, and building satellite sites to expand access to PH experts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Patients with PH experience significant barriers to receiving timely PH care along their entire health journey. Comprehensive transformations to PH care delivery and health policies are needed to mitigate delays and improve quality of care for patients living with this disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-025-03817-4","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:40:16Z","timestamp":1753684816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-259X","authenticated-orcid":false,"given":"Kari R.","family":"Gillmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shusterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-1224","authenticated-orcid":false,"given":"Seppo T.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-3118","authenticated-orcid":false,"given":"A. Rani","family":"Elwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-2135","authenticated-orcid":false,"given":"Renda Soylemez","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"3817_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS). Endorsed by the international society for heart and lung transplantation (ISHLT) and the European reference network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43:3618\u2013731.","journal-title":"Eur Heart J"},{"key":"3817_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2023.08.004","author":"K Kubota","year":"2023","unstructured":"Kubota K, Miyanaga S, Akao M, Mitsuyoshi K, Iwatani N, Higo K, et al. Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis. J Cardiol. 2023. https:\/\/doi.org\/10.1016\/j.jjcc.2023.08.004.","journal-title":"J Cardiol"},{"key":"3817_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2017.12.016","volume":"254","author":"CD Vizza","year":"2018","unstructured":"Vizza CD, Badagliacca R, Messick CR, Rao Y, Nelsen AC, Benza RL. The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis. Int J Cardiol. 2018;254:299\u2013301.","journal-title":"Int J Cardiol"},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","volume":"53","author":"A Frost","year":"2019","unstructured":"Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53:1801904.","journal-title":"Eur Respir J"},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","volume":"65","author":"VV McLaughlin","year":"2015","unstructured":"McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of pulmonary arterial hypertension. J Am Coll Cardiol. 2015;65:1976\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"3817_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.chest.2020.03.079","volume":"158","author":"MM Chakinala","year":"2020","unstructured":"Chakinala MM, Farber HW. Pulmonary arterial hypertension and specialty care centers: we had a feeling; now we have data. Chest. 2020;158:28\u201330.","journal-title":"Chest"},{"key":"3817_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.chest.2020.01.046","volume":"158","author":"H Pi","year":"2020","unstructured":"Pi H, Kosanovich CM, Handen A, Tao M, Visina J, Vanspeybroeck G, et al. Outcomes of pulmonary arterial hypertension are improved in a specialty care center. Chest. 2020;158:330\u201340.","journal-title":"Chest"},{"key":"3817_CR8","unstructured":"Wetherill J. Pulmonary Hypertension Awareness Month. Pulmonary Hypertension Association. https:\/\/phassociation.org\/awarenessmonth\/. Accessed 27 Mar 2024."},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"e12188","DOI":"10.1002\/pul2.12188","volume":"13","author":"E-M Didden","year":"2023","unstructured":"Didden E-M, Lee E, Wyckmans J, Quinn D, Perchenet L. Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data. Pulm Circ. 2023;13:e12188.","journal-title":"Pulm Circ"},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","volume":"107","author":"S Rich","year":"1987","unstructured":"Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension. A National prospective study. Ann Intern Med. 1987;107:216\u201323.","journal-title":"Ann Intern Med"},{"key":"3817_CR11","doi-asserted-by":"publisher","first-page":"e12330","DOI":"10.1002\/pul2.12330","volume":"14","author":"G Kope\u0107","year":"2024","unstructured":"Kope\u0107 G, Forfia P, Abe K, Beaudet A, Gressin V, Jevnikar M, et al. Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY). Pulm Circ. 2024;14:e12330.","journal-title":"Pulm Circ"},{"key":"3817_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jamainternmed.2013.319","volume":"173","author":"RC Dea\u00f1o","year":"2013","unstructured":"Dea\u00f1o RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter repherral study. JAMA Intern Med. 2013;173:887\u201393.","journal-title":"JAMA Intern Med"},{"key":"3817_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/diseases10010005","volume":"10","author":"H Saunders","year":"2022","unstructured":"Saunders H, Helgeson SA, Abdelrahim A, Rottman-Pietrzak K, Reams V, Zeiger TK, et al. Comparing diagnosis and treatment of pulmonary hypertension patients at a pulmonary hypertension center versus community centers. Diseases. 2022;10:5.","journal-title":"Diseases"},{"key":"3817_CR14","doi-asserted-by":"publisher","first-page":"e12171","DOI":"10.1002\/pul2.12171","volume":"12","author":"KR Gillmeyer","year":"2022","unstructured":"Gillmeyer KR, Rinne ST, Qian SX, Maron BA, Johnson SW, Klings ES, et al. Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension. Pulm Circ. 2022;12:e12171.","journal-title":"Pulm Circ"},{"key":"3817_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/2045-8932.109919","volume":"3","author":"G Strange","year":"2013","unstructured":"Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, et al. Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study. Pulm Circ. 2013;3:89\u201394.","journal-title":"Pulm Circ"},{"key":"3817_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/resp.13768","volume":"25","author":"V Khou","year":"2020","unstructured":"Khou V, Anderson JJ, Strange G, Corrigan C, Collins N, Celermajer DS, et al. Diagnostic delay in pulmonary arterial hypertension: insights from the Australian and new Zealand pulmonary hypertension registry. Respirology. 2020;25:863\u201371.","journal-title":"Respirology"},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"00100","DOI":"10.1183\/23120541.00100-2018","volume":"4","author":"M Ginoux","year":"2018","unstructured":"Ginoux M, Turquier S, Chebib N, Glerant J-C, Traclet J, Philit F, et al. Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension. ERJ Open Res. 2018;4:00100\u20132018.","journal-title":"ERJ Open Res"},{"key":"3817_CR18","doi-asserted-by":"publisher","first-page":"215013272110292","DOI":"10.1177\/21501327211029241","volume":"12","author":"B Ivarsson","year":"2021","unstructured":"Ivarsson B, Johansson A, Kjellstr\u00f6m B. The odyssey from symptom to diagnosis of pulmonary hypertension from the patients and spouses perspective. J Prim Care Community Health. 2021;12:21501327211029241.","journal-title":"J Prim Care Community Health"},{"key":"3817_CR19","doi-asserted-by":"publisher","first-page":"e000806","DOI":"10.1136\/bmjopen-2011-000806","volume":"2","author":"I Armstrong","year":"2012","unstructured":"Armstrong I, Rochnia N, Harries C, Bundock S, Yorke J. The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study. BMJ Open. 2012;2:e000806.","journal-title":"BMJ Open"},{"key":"3817_CR20","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.lpm.2015.06.017","volume":"45","author":"S Alami","year":"2016","unstructured":"Alami S, Cottin V, Mouthon L, Desjeux D, Quessette E, Poiraudeau S, et al. Patients\u2019, relatives\u2019, and practitioners\u2019 views of pulmonary arterial hypertension: A qualitative study. La Presse M\u00e9dicale. 2016;45:e11\u201327.","journal-title":"La Presse M\u00e9dicale"},{"key":"3817_CR21","unstructured":"HIV Care Continuum. HIV.gov. https:\/\/www.hiv.gov\/federal-response\/policies-issues\/hiv-aids-care-continuum. Accessed 27 Mar 2024."},{"key":"3817_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533\u201344.","journal-title":"Adm Policy Ment Health"},{"key":"3817_CR23","doi-asserted-by":"crossref","unstructured":"Mendez A. Enlisting the gatekeeper: Chain-Referral and elite access in foreign policy analysis. Thousand Oaks: SAGE Publications Ltd; 2020.","DOI":"10.4135\/9781529711318"},{"key":"3817_CR24","doi-asserted-by":"publisher","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523.","journal-title":"Soc Sci Med"},{"key":"3817_CR25","unstructured":"Three Approaches to Qualitative Content Analysis - Hsiu-Fang, Hsieh SE, Shannon. 2005. https:\/\/journals.sagepub.com\/doi\/10.1177\/1049732305276687. Accessed 5 Oct 2023."},{"key":"3817_CR26","doi-asserted-by":"publisher","first-page":"1801919","DOI":"10.1183\/13993003.01919-2018","volume":"53","author":"MD McGoon","year":"2019","unstructured":"McGoon MD, Ferrari P, Armstrong I, Denis M, Howard LS, Lowe G, et al. The importance of patient perspectives in pulmonary hypertension. Eur Respir J. 2019;53:1801919.","journal-title":"Eur Respir J"},{"key":"3817_CR27","doi-asserted-by":"publisher","first-page":"e026413","DOI":"10.1161\/JAHA.122.026413","volume":"12","author":"E de Belen","year":"2023","unstructured":"de Belen E, McConnell JW, Elwing JM, Paculdo D, Cabaluna I, Linder J, et al. Gaps in the care of pulmonary hypertension: A Cross-Sectional patient simulation study among practicing cardiologists and pulmonologists. J Am Heart Assoc. 2023;12:e026413.","journal-title":"J Am Heart Assoc"},{"key":"3817_CR28","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1378\/chest.09-2816","volume":"137","author":"CG Elliott","year":"2010","unstructured":"Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, Zamanian RT, et al. Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest. 2010;137:S85\u201394.","journal-title":"Chest"},{"key":"3817_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/ACM.0000000000004749","volume":"97","author":"J-A Osei-Twum","year":"2022","unstructured":"Osei-Twum J-A, Wiles B, Killackey T, Mahood Q, Lalloo C, Stinson JN. Impact of project ECHO on patient and community health outcomes: A scoping review. Acad Med. 2022;97:1393\u2013402.","journal-title":"Acad Med"},{"key":"3817_CR30","doi-asserted-by":"publisher","first-page":"e12340","DOI":"10.1002\/pul2.12340","volume":"14","author":"S Ahmed","year":"2024","unstructured":"Ahmed S, Ahmed A, R\u00e5degran G. Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulm Circ. 2024;14:e12340.","journal-title":"Pulm Circ"},{"key":"3817_CR31","first-page":"489","volume":"34","author":"MM Chakinala","year":"2016","unstructured":"Chakinala MM, Duncan M, Wirth J. Managing the patient with pulmonary hypertension: specialty care centers, coordinated care, and patient support. Cardiol Clin. 2016;34:489\u2013500.","journal-title":"Cardiol Clin"},{"key":"3817_CR32","unstructured":"Call to Action on the Unmet Needs of Patients with Pulmonary Hypertension.\u2013 2012. PHA Europe. 2024. https:\/\/www.phaeurope.org\/get-involved\/advocacy-policy-work\/call-to-action-on-the-unmet-needs-of-patients-with-pulmonary-hypertension-2012\/. Accessed 24 Oct 2024."},{"key":"3817_CR33","unstructured":"ERN-LUNG - Pulmonary hypertension (PH). ERS Respiratory Channel. https:\/\/channel.ersnet.org\/\\\\channel.ersnet.org\/fo-channel-home.php?id=160&contId. Accessed 24 Oct 2024."},{"key":"3817_CR34","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1378\/chest.09-2960","volume":"137","author":"AA Lopes","year":"2010","unstructured":"Lopes AA, Bandeira AP, Flores PC, Tavares Santana MV. Pulmonary hypertension in Latin america: pulmonary vascular disease: the global perspective. Chest. 2010;137:S78\u201384.","journal-title":"Chest"},{"key":"3817_CR35","doi-asserted-by":"publisher","first-page":"101623","DOI":"10.1016\/j.cpcardiol.2023.101623","volume":"48","author":"R Issa","year":"2023","unstructured":"Issa R, Minhas AMK, Issa R, Ariss RW, Nazir S, Satti DI, et al. Urban-Rural disparities in pulmonary Hypertension-Related mortality between 2004 and 2019: A call to improve access to specialty care centers for rural residents in the united States. Curr Probl Cardiol. 2023;48:101623.","journal-title":"Curr Probl Cardiol"},{"key":"3817_CR36","unstructured":"PHA A. PH Care Centers - Accredited Centers. Pulmonary Hypertension Association. https:\/\/phassociation.org\/phcarecenters\/accredited-centers\/. Accessed 3 Apr 2024."},{"key":"3817_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1513\/AnnalsATS.202003-234RL","volume":"17","author":"CG Mac\u00edas","year":"2020","unstructured":"Mac\u00edas CG, Wharam JF, Maron BA, Ong M-S. Urban\u2013Rural disparities in pulmonary hypertension mortality. Annals ATS. 2020;17:1168\u201371.","journal-title":"Annals ATS"},{"key":"3817_CR38","doi-asserted-by":"publisher","first-page":"e29575","DOI":"10.2196\/29575","volume":"23","author":"M Butzner","year":"2021","unstructured":"Butzner M, Cuffee Y. Telehealth interventions and outcomes across rural communities in the united states: narrative review. J Med Internet Res. 2021;23:e29575.","journal-title":"J Med Internet Res"},{"key":"3817_CR39","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1080\/09540121.2018.1481194","volume":"30","author":"BR Wood","year":"2018","unstructured":"Wood BR, Bell C, Carr J, Aleshire R, Behrens CB, Dunaway SB, et al. Washington state satellite HIV clinic program: a model for delivering highly effective decentralized care in under-resourced communities. AIDS Care. 2018;30:1120\u20137.","journal-title":"AIDS Care"},{"key":"3817_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/21501351221149420","volume":"14","author":"DA Katz","year":"2023","unstructured":"Katz DA, Mohan S, Bacon M, McGovern E, Wallen WJ, Preston GM, et al. Regionalization or access to care?? A joint pediatric heart care? program that achieves both: one program-Two sites. World J Pediatr Congenit Heart Surg. 2023;14:155\u201360.","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"3817_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1086\/686489","volume":"6","author":"A Talwar","year":"2016","unstructured":"Talwar A, Sahni S, Talwar A, Kohn N, Klinger JR. Socioeconomic status affects pulmonary hypertension disease severity at time of first evaluation. Pulmonary Circulation. 2016;6:191\u20135.","journal-title":"Pulmonary Circulation"},{"key":"3817_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1164\/rccm.201207-1290OC","volume":"187","author":"W-H Wu","year":"2013","unstructured":"Wu W-H, Yang L, Peng F-H, Yao J, Zou L-L, Liu D, et al. Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;187:303\u201310.","journal-title":"Am J Respir Crit Care Med"},{"key":"3817_CR43","doi-asserted-by":"publisher","first-page":"e003973","DOI":"10.1161\/CIRCOUTCOMES.117.003973","volume":"11","author":"DT Wijeratne","year":"2018","unstructured":"Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, et al. Increasing incidence and prevalence of world health organization groups 1 to 4 pulmonary hypertension: A Population-Based cohort study in ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018;11:e003973.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3817_CR44","unstructured":"Kudelko K, Zamanian RT, De Jesus Perez VA. Pulmonary Vascular Fellowship Training to Promote Excellence in PH Clinical Care: The Stanford Perspective. 2020. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/09\/21\/19\/13\/pulmonary-vascular-fellowship-training-to-promote-excellence-in-ph-clinical-care. Accessed 3 Apr 2024."},{"key":"3817_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/diseases8020022","volume":"8","author":"SA Helgeson","year":"2020","unstructured":"Helgeson SA, Menon D, Helmi H, Vadlamudi C, Moss JE, Zeiger TK, et al. Psychosocial and financial burden of therapy in USA patients with pulmonary arterial hypertension. Diseases. 2020;8:22.","journal-title":"Diseases"},{"key":"3817_CR46","unstructured":"Wetherill J. Apr. Financial Assistance. Pulmonary Hypertension Association. https:\/\/phassociation.org\/patients\/insurance-and-treatment-access\/financialassist\/.\u00a0Accessed 3 Apr 2024."},{"key":"3817_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1074248419877409","volume":"25","author":"S Narechania","year":"2020","unstructured":"Narechania S, Torbic H, Tonelli AR. Treatment discontinuation or interruption in pulmonary arterial hypertension. J Cardiovasc Pharmacol Ther. 2020;25:131\u201341.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"3817_CR48","first-page":"e25552","volume":"14","author":"S Murali","year":"2022","unstructured":"Murali S, Khanal S, Banerjee S, Christie O, Ramakrishna K. Pause at your own peril: A case series on rebound pulmonary hypertension. Cureus. 2022;14:e25552.","journal-title":"Cureus"},{"issue":"7 Suppl","key":"3817_CR49","first-page":"S119","volume":"25","author":"KB Highland","year":"2019","unstructured":"Highland KB, Hughes KE, Williams KJ, Kyei-Baffour B, Ferguson S. Ensuring appropriate access to pulmonary arterial hypertension therapy. Am J Manag Care. 2019;25(7 Suppl):S119\u201327.","journal-title":"Am J Manag Care"},{"key":"3817_CR50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/CEOR.S119117","volume":"9","author":"CD Burger","year":"2017","unstructured":"Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL. Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes. Clinicoecon Outcomes Res. 2017;9:731\u20139.","journal-title":"Clinicoecon Outcomes Res"},{"key":"3817_CR51","first-page":"834","volume":"24","author":"CD Burger","year":"2018","unstructured":"Burger CD, Ozbay AB, Lazarus HM, Riehle E, Montejano LB, Lenhart G, et al. Treatment patterns and associated health care costs before and after treatment initiation among pulmonary arterial hypertension patients in the united States. J Manag Care Spec Pharm. 2018;24:834\u201342.","journal-title":"J Manag Care Spec Pharm"},{"key":"3817_CR52","doi-asserted-by":"publisher","first-page":"e12012","DOI":"10.1002\/pul2.12012","volume":"12","author":"M Orozco-Levi","year":"2022","unstructured":"Orozco-Levi M, C\u00e1neva J, Fernandes C, Restrepo-Jaramillo R, Zayas N, Conde R, et al. Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America. Pulmonary Circulation. 2022;12:e12012.","journal-title":"Pulmonary Circulation"},{"key":"3817_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12931-019-1228-2","volume":"20","author":"D Pritchard","year":"2019","unstructured":"Pritchard D, Adegunsoye A, Lafond E, Pugashetti JV, DiGeronimo R, Boctor N, et al. Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019;20:253.","journal-title":"Respir Res"},{"key":"3817_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1513\/AnnalsATS.202102-216OC","volume":"19","author":"KA Johannson","year":"2022","unstructured":"Johannson KA, Lethebe BC, Assayag D, Fisher JH, Kolb M, Morisset J, et al. Travel distance to subspecialty clinic and outcomes in patients with fibrotic interstitial lung disease. Ann Am Thorac Soc. 2022;19:20\u20137.","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl 6","key":"3817_CR55","doi-asserted-by":"publisher","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","volume":"14","author":"AK Gerke","year":"2017","unstructured":"Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease burden and variability in sarcoidosis. Ann Am Thorac Soc. 2017;14(Suppl 6):S421\u20138.","journal-title":"Ann Am Thorac Soc"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03817-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:02:40Z","timestamp":1757304160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03817-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Boston University Institutional Review Board deemed this study to be exempt under Category 2 of The Common Rule (H-41416). In compliance with this exempt category, abbreviated verbal consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}